We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $357M
1-Year Est. Return 13.97%
This Fund
S&P 500
This Quarter Est. Return
+0.76%
1 Year Est. Return
+13.97%
3 Year Est. Return
+50.79%
5 Year Est. Return
+74.78%
10 Year Est. Return
+368.42%
AUM
$6.9B
AUM Growth
-$199M
Cap. Flow
-$157M
Cap. Flow %
-2.27%
Top 10 Hldgs %
24.04%
Holding
3,083
New
373
Increased
407
Reduced
1,584
Closed
241

Top Buys

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$121M
2
MDT icon
Medtronic
MDT
+$20.5M
3
IWF icon
iShares Russell 1000 Growth ETF
IWF
+$17.3M
4
LIN icon
Linde
LIN
+$15.1M
5
MRNA icon
Moderna
MRNA
+$12.2M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$17.5M
2
MSFT icon
Microsoft
MSFT
+$12.3M
3
AAPL icon
Apple
AAPL
+$12.2M
4
AMZN icon
Amazon
AMZN
+$5.77M
5
META icon
Meta Platforms (Facebook)
META
+$5.08M

Sector Composition

Rank Sector Weight
1 Technology 24.1%
2 Healthcare 12.61%
3 Financials 12.48%
4 Consumer Discretionary 12.33%
5 Communication Services 9.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KEX icon
1426
Kirby Corp
KEX
$7.33B
$526K 0.01%
10,963
-383
-3% -$21.2K
MNRO icon
1427
Monro
MNRO
$353M
$526K 0.01%
9,141
– –
CHRD icon
1428
Chord Energy
CHRD
$7.59B
$525K 0.01%
5,278
-498
-9% -$45.8K
SANA icon
1429
Sana Biotechnology
SANA
$1.04B
$524K 0.01%
23,286
+14,416
+163% +$303K
PFSI icon
1430
PennyMac Financial
PFSI
$4.12B
$523K 0.01%
8,560
-1,151
-12% -$73.1K
LILAK icon
1431
Liberty Latin America Class C
LILAK
$1.66B
$523K 0.01%
+43,868
New +$545K
SILK
1432
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$522K 0.01%
9,484
– –
MFA
1433
MFA Financial
MFA
$933M
$522K 0.01%
28,535
+3,805
+15% +$70.7K
PRAA icon
1434
PRA Group
PRAA
$777M
$521K 0.01%
12,360
– –
VRRM icon
1435
Verra Mobility
VRRM
$720M
$521K 0.01%
34,549
+1,995
+6% +$30.5K
COKE icon
1436
Coca-Cola Consolidated
COKE
$12.7B
$519K 0.01%
13,160
– –
TRIL
1437
DELISTED
Trillium Therapeutics Inc.
TRIL
$518K 0.01%
29,523
– –
TEVA icon
1438
Teva Pharmaceuticals
TEVA
$42.3B
$518K 0.01%
53,172
– –
ODP
1439
DELISTED
ODP
ODP
$518K 0.01%
+12,892
New +$580K
XNCR icon
1440
Xencor
XNCR
$1.68B
$518K 0.01%
15,851
– –
HOUS
1441
DELISTED
Anywhere Real Estate
HOUS
$517K 0.01%
29,489
-2,809
-9% -$49.5K
PRLB icon
1442
Protolabs
PRLB
$2.2B
$515K 0.01%
7,729
– –
GTN icon
1443
Gray Television
GTN
$530M
$515K 0.01%
22,554
– –
RLAY icon
1444
Relay Therapeutics
RLAY
$4.3B
$513K 0.01%
16,284
– –
BFLY icon
1445
Butterfly Network
BFLY
$2.29B
$513K 0.01%
49,156
+37,930
+338% +$438K
SPWR
1446
DELISTED
SunPower Corporation Common Stock
SPWR
$513K 0.01%
22,622
– –
BGS icon
1447
B&G Foods
BGS
$293M
$513K 0.01%
17,151
-1,928
-10% -$57.8K
SWTX
1448
DELISTED
SpringWorks Therapeutics
SWTX
$513K 0.01%
+8,079
New +$623K
CORT icon
1449
Corcept Therapeutics
CORT
$12.1B
$511K 0.01%
25,966
-2,360
-8% -$49.4K
FLGT icon
1450
Fulgent Genetics
FLGT
$509M
$511K 0.01%
5,679
– –
56 57
58
59 60

Similar funds

RM
Rudius Management New York $358M AUM 12.23% 1-Year Est. Return
SPM
Symmetry Peak Management Radnor, Pennsylvania $359M AUM 146.87% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $359M AUM 8.03% 1-Year Est. Return
SFP
Sandbox Financial Partners Bethesda, Maryland $356M AUM 19.83% 1-Year Est. Return
RIP
Rhino Investment Partners West Conshohocken, Pennsylvania $359M AUM 22.33% 1-Year Est. Return
KLWA
Kelly Lawrence W & Associates Pasadens, California $360M AUM 16.9% 1-Year Est. Return
LSC
Logan Stone Capital Chicago, Illinois $360M AUM 9.71% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s Q3 2021 Portfolio in Review

As of Q3 2021, Metropolitan Life Insurance Company (MetLife) held 3,083 positions worth $6.9B, down 2.8% from $7.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Metropolitan Life Insurance Company (MetLife)'s Q3 2021 filing shows 373 new, 407 increased, 1,584 reduced and 241 closed positions. Its largest new stake was Alphabet (Google) Class C: 878,340 shares worth $117M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $17.5M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q3 2021 buy was Alphabet (Google) Class C: 878,340 shares worth $117M.
  • Metropolitan Life Insurance Company (MetLife) added most to iShares Russell 1000 Growth ETF in Q3 2021, an estimated $17.3M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q3 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $17.5M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $4.87M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 24% of its $6.9B portfolio in Q3 2021.
  • Metropolitan Life Insurance Company (MetLife) opened 373 new positions and closed 241 in Q3 2021.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value fell 2.8% quarter-over-quarter to $6.9B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q3 2021, filed 15 Nov 2021.